TABLE 3.
Main bacterial groups or the group with significant difference (%).
Group | Control group |
Treatment group |
P-value | ||||||
C0 | C14 | C28 | C42 | S0 | S14 | S28 | S42 | ||
At phylum level | |||||||||
Proteobacteria | 25.3 | 24.7 | 31.2 | 23.9 | 28.6 | 32.8 | 37.4 | 40.6 | 0.43 |
Bacteroidetes | 15.3 | 18.5 | 26.7 | 18.2 | 20.1 | 27.2 | 28.9 | 17.1 | 0.31 |
Acidobacteria | 16.0 | 15.5 | 10.8 | 16.4 | 11.9 | 8.09 | 9.04 | 9.95 | 0.30 |
Planctomycetes | 6.48 | 7.99 | 7.14 | 9.26 | 6.84 | 5.99 | 5.59 | 4.78 | 0.42 |
At genus level | |||||||||
Flavobacterium | 1.60 | 4.06 | 11.4 | 4.10 | 3.66 | 9.00 | 13.7 | 6.49 | 0.19 |
Candidatus Nitrosotalea | 9.53 | 0.62 | 0.19 | 0.34 | 3.73 | 2.90 | 0.89 | 2.13 | 0.08 |
Pseudomonas | 0.29 | 1.55 | 1.49 | 0.92 | 0.29 | 4.87 | 4.69 | 5.67 | 0.53 |
Stenotrophomonas | 0.02 | 0.36 | 5.21 | 0.35 | 0.01 | 3.05 | 2.46 | 5.15 | 0.66 |
Sphingomonas | 1.44 | 1.35 | 1.42 | 1.15 | 2.38 | 1.48 | 1.81 | 2.38 | 0.55 |
Flavisolibacter | 1.33 | 1.50 | 1.38 | 1.48 | 1.47 | 1.19 | 1.00 | 0.91 | 0.74 |
Gemmatimonas | 1.06 | 1.35 | 1.31 | 1.56 | 0.90 | 0.99 | 0.94 | 1.34 | 0.75 |
Bryobacter | 1.28 | 1.22 | 1.16 | 1.37 | 0.92 | 1.01 | 1.07 | 1.23 | 0.98 |
Acidovorax | 0.74b | 1.02b | 2.02a | 1.19ab | 0.92b | 0.72b | 1.42ab | 0.86b | 0.01 |
Pedobacter | 0.31 | 0.25 | 1.48 | 0.40 | 0.27 | 1.42 | 2.23 | 0.77 | 0.17 |
Chitinophaga | 0.01 | 0.14 | 0.13 | 0.28 | 0.00 | 3.23 | 1.61 | 1.33 | 0.60 |
Haliangium | 1.06ab | 0.56bc | 0.49bc | 0.63abc | 1.22a | 0.44bc | 0.33c | 0.49bc | 0.00 |
Ferruginibacter | 0.37 | 1.09 | 0.71 | 0.96 | 0.31 | 0.65 | 0.52 | 0.34 | 0.05 |
Herbaspirillum | 0.18b | 0.38b | 0.30b | 0.18b | 0.16b | 0.22b | 1.12a | 0.33b | 0.03 |
Mizugakiibacter | 0.92a | 0.07b | 0.22b | 0.14b | 1.12a | 0.07b | 0.09b | 0.18b | 0.00 |
n = 3; different letters (a, b, or c) for same item indicate significant differences at P < 0.05 level; C0, C14, C28, and C42 represent the sampling days 0, 14, 28, and 42 in the control group, respectively; S0, S14, S28, and S42 represent the sampling days of the treatment group.